VICINIUM TRIALS

Eligibility

Ages Eligible for Study: 18 Years and above,
Genders Eligible for Study: Both

Inclusion Criteria
(what you must have in order to enter the trial):


Disease Characteristics

  • You have Transitional Cell Carcinoma (TCC) of the bladder
  • You have Carcinoma In Situ (CIS), with or without non-invasive papillary disease (Ta or T1)
  • The cancer cells express the EpCAM molecule (which you will be tested for once you enter the study)
  • You have received BCG therapy within the past 2 years for this bladder cancer but the cancer persisted or came back

Prior/Concurrent Therapy

  • It has been at least 2 months since the last dose of anti-cancer therapy (eg, chemotherapy, biological therapy, or photodynamic therapy) or any investigational therapy.

Patient Characteristics

  • No hydronephrosis
  • No significant liver or kidney disease
Other
  • Patients must not become pregnant while participating in this trial

Exclusion Criteria
(reasons you will not be allowed to enter into the trial):

  • You have muscle-invasive bladder cancer
  • Your bladder cancer has spread outside of the bladder
  • You have a severe urinary tract infection
  • You can not tolerate intravesical administration

 

 
Copyright 2007 © VICINIUM™. All rights reserved.

The content of this site is for informational purposes only and is not intended to replace the advice of a health care professional.
Please consult your doctor if you have any questions regarding the information contained in this site.